Svmuu News CryptoQuant's analysis report indicates that internal demand in the Bitcoin market has been contracting significantly in the first three months of 2026. The overall 30-day net demand stands at -63,000 BTC. Despite accelerated institutional buying (approximately 50,000 BTC via ETFs and 44,000 BTC via Strategy), the market has seen selling of about 157,000 BTC from retail investors, old whales, and miners.
Large holders (1,000–10,000 BTC) have shifted from being the market's largest buyers to its largest sellers, distributing a cumulative ~188,000 BTC over the past year. Medium-sized holders (100–1,000 BTC) are still buying, but their accumulation rate has dropped by over 60% since October 2025. The Bitcoin spot price remains in the $67,000–$68,000 range, still at a ~21% premium compared to the weighted average cost of $54,286, indicating most holders are still in profit and the market has not yet bottomed.
Market sentiment and capital flows are decoupled: the Fear & Greed Index is in the Extreme Fear zone (8–14), yet ETF net inflows exceeded $1 billion in March. The Coinbase Premium Index remains negative, reflecting limited participation from U.S. institutions. Geopolitical volatility (Iran conflict) has caused repeated price swings, leading market strategies to lean towards a wait-and-see approach, with overall demand slowly fading rather than panic selling.
Despite a ~47% decline from the October 2025 all-time high of $126,000, which is far below the 85%+ crashes seen in 2013 and 2017, Zack Wainwright points out that this reflects the Bitcoin market's gradual maturation, with volatility compressing over time.
Potential catalysts include: Morgan Stanley's approval of a low-fee Bitcoin ETF, which would provide access for $6.2 trillion in assets managed by 16,000 financial advisors, and the Strategy STRC preferred share product's continued monthly purchases of 44,000 BTC, potentially providing stable buying pressure for the market. Short-term technical indicators suggest that if the Iran conflict eases, Bitcoin could rebound to the $71,500–$81,200 range.
Synthesizing relevant indicators, CryptoQuant concludes: Internal demand in the Bitcoin market is contracting. Current price support relies on institutional ETFs, Strategy, and new channels continuously absorbing selling pressure from retail investors and large holders. (CoinDesk)
Analysis: Bitcoin Demand Contracts Internally, Multiple Indicators Show Clear Retail and Whale Selling
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
6
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
9
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
10
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
Markets Today
Recommended Reading






